Study reveals best commercial weight loss program for quick results
NCT ID NCT06972277
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study compared three commercial weight management programs to see which helps adults with overweight or obesity lose the most weight in 12 weeks. 459 participants were randomly assigned to one of the programs. The main goal was to measure weight change and percentage of body weight lost.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- commercial weight management program (behavioral/lifestyle support)
- What this could lead to
- If successful, this could help identify which commercial weight loss program works best for short-term weight loss in adults with overweight or obesity.
- What could go wrong
- This is a completed study with 459 participants, but results may not apply to everyone. Weight loss at 12 weeks may not be sustained long-term, and individual results vary.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
459 people
The number who actually took part.
- Started
-
May 2025
- Finished
-
Jan 2026
- Lead sponsor
-
A company
The lead sponsor is a pharmaceutical, biotech, or medical-device company.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * 18 years or older * BMI ≥27 kg/m² * Own a bodyweight scale that they can weigh themselves with during the study * Willing and able to comply with study protocol * Capable of providing informed consent * Able to read and write in English * Willing to be randomized * Willing to sign a Non Disclosure Agreement Exclusion Criteria: * Pregnant, lactating, or plans to become pregnant in the next 6 months * Previous bariatric surgery or planned bariatric surgery during the study period * Major surgery within the past 6 months or plans to have surgery during the study period * Participation in the previous 3 months or current participation in a structured behavioral weight loss program * Participation in another structured weight loss program during the study period (i.e., the next 3 months) * Communication needs that would render them unable to understand the study and/or intervention materials * Current or previous history of anorexia or bulimia nervosa * Engagement with vomiting or laxative use within the last 28 days with the aim of controlling their shape or weight * Currently taking anti-obesity medications, planning to take anti-obesity medications in the next 6 months, or previously taken anti-obesity medications in the previous 3 months * Weight loss of ≥ 5 kg (11 lb) in the previous 6 months * Self-reported diagnosis of severe depression, bipolar disorder, substance abuse, or psychosis * Participants who are involved in any other research studies at this time * Untreated thyroid disease or any changes (type or dose) in thyroid medication in last 6 months * Chronic/inflammatory gastrointestinal disorders (irritable bowel syndrome is acceptable) * History of heart problems (e.g., angina, bypass surgery, myocardial infarction, etc.) within previous 6 months * Diagnosis of type 1 or type 2 diabetes * Presence of implanted cardiac defibrillator or pacemaker * History of cancer within past 5 years or current treatment for cancer * Hospitalization for psychiatric disorders during the last 12 months
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Obesity and overweight are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
WW International, Inc
New York, New York, 10010, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- New injection IBI3046 tested for weight management
- One-Size-Fits-All diets may be outdated: personalized plans put to the test
- Can timing your carbs tame metabolic risk?
- Home visits may boost heart health for pregnant women in nigeria
- Could a diabetes drug protect obese Teens' hearts?
- Could a biweekly shot rival weekly Weight-Loss drugs?